{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:28:44Z","timestamp":1790378924582,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"42","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.vaccine.2007.08.017","type":"journal-article","created":{"date-parts":[[2007,8,31]],"date-time":"2007-08-31T11:14:53Z","timestamp":1188558893000},"page":"7307-7312","source":"Crossref","is-referenced-by-count":22,"title":["Universal mass vaccination against varicella in Germany using an MMRV combination vaccine with a two-dose schedule: An economic analysis"],"prefix":"10.1016","volume":"25","author":[{"given":"Thomas","family":"Hammerschmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmtrud","family":"Bisanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wutzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.08.017_bib1","first-page":"9","article-title":"Impfempfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut (RKI)\/Stand: Januar 2000 [Vaccination recommendation of the Standing Committee on Vaccinations (STIKO)\/Status: January 2000]","volume":"2","author":"Robert Koch-Institute","year":"2000","journal-title":"Epidemiol Bull"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2007.08.017_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0264-410X(01)00276-6","article-title":"Seroprevalence of varicella-zoster virus in the German population","volume":"20","author":"Wutzler","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.08.017_bib3","first-page":"203","article-title":"Impfempfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut (RKI)\/Stand: Juli 2001 [Vaccination recommendation of the Standing Committee on Vaccinations (STIKO)\/Status: July 2001]","volume":"28","author":"Robert Koch-Institute","year":"2001","journal-title":"Epidemiol Bull"},{"issue":"5","key":"10.1016\/j.vaccine.2007.08.017_bib4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1469-0691.2004.00853.x","article-title":"Empirical data on the varicella situation in Germany for vaccination decisions","volume":"10","author":"Wagenpfeil","year":"2004","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.vaccine.2007.08.017_bib5","doi-asserted-by":"crossref","first-page":"E79","DOI":"10.1542\/peds.108.5.e79","article-title":"Severe complications of varicella in previously healthy children in Germany: a 1-year survey","volume":"108","author":"Ziebold","year":"2001","journal-title":"Pediatrics"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2007.08.017_bib6","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0264-410X(02)00431-0","article-title":"The cost-effectiveness of routine childhood varicella vaccination in Germany","volume":"21","author":"Banz","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2007.08.017_bib7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1524-4733.2005.04005.x","article-title":"The economic value of childhood varicella vaccination in France and Germany","volume":"8","author":"Coudeville","year":"2005","journal-title":"Value Health"},{"issue":"5","key":"10.1016\/j.vaccine.2007.08.017_bib8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJMoa042271","article-title":"Decline in mortality due to varicella after implementation of varicella vaccination in the United States","volume":"352","author":"Nguyen","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2007.08.017_bib9","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.287.5.606","article-title":"Varicella disease after introduction of varicella vaccine in the United States, 1995\u20132000","volume":"287","author":"Seward","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2007.08.017_bib10","first-page":"235","article-title":"Impfempfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut (RKI)\/Stand: Juli 2004 [Vaccination recommendation of the Standing Committee on Vaccinations (STIKO)\/Status: July 2004]","volume":"30","author":"Robert Koch-Institute","year":"2004","journal-title":"Epidemiol Bull"},{"issue":"5","key":"10.1016\/j.vaccine.2007.08.017_bib11","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1524-4733.2003.65241.x","article-title":"Validation of health economic models: the example of EVITA","volume":"6","author":"Hammerschmidt","year":"2003","journal-title":"Value Health"},{"key":"10.1016\/j.vaccine.2007.08.017_bib12","first-page":"235","article-title":"Impfempfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut (RKI)\/Stand: Januar 2006 [Vaccination recommendation of the Standing Committee on Vaccinations (STIKO)\/Status: July 2006]","volume":"30","author":"Robert Koch-Institue","year":"2006","journal-title":"Epidemiol Bull"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2007.08.017_bib13","doi-asserted-by":"crossref","first-page":"S330","DOI":"10.1093\/infdis\/174.Supplement_3.S330","article-title":"Efficacy of high-titer live attenuated varicella vaccine in healthy young children","volume":"174","author":"Varis","year":"1996","journal-title":"J Infect Dis"},{"issue":"RR-15","key":"10.1016\/j.vaccine.2007.08.017_bib14","first-page":"1","article-title":"General Recommendations on Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Kroger","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"6","key":"10.1016\/j.vaccine.2007.08.017_bib15","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/01.inf.0000219484.55858.a2","article-title":"Control of varicella: why is a two-dose schedule necessary?","volume":"25","author":"Arvin","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2007.08.017_bib16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Ten year follow-up of healthy children who received one or two injections of varicella vaccine","volume":"23","author":"Kuter","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.017_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0264-410X(00)00154-7","article-title":"The hidden costs of infant vaccination","volume":"19","author":"Lieu","year":"2000","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2007.08.017_bib18","first-page":"S6","article-title":"Benefits of combination vaccines: effective vaccination on a simplified schedule","volume":"9","author":"Dodd","year":"2003","journal-title":"Am J Manag Care"},{"issue":"4","key":"10.1016\/j.vaccine.2007.08.017_bib19","first-page":"314","article-title":"Pediatric combination vaccines: their impact on patients, providers, managed care organizations, and manufacturers","volume":"9","author":"Marcy","year":"2003","journal-title":"Am J Manag Care"},{"issue":"6","key":"10.1016\/j.vaccine.2007.08.017_bib20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/01.inf.0000222413.47344.23","article-title":"The use of combination vaccines has improved timeliness of vaccination in children","volume":"25","author":"Kalies","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.017_bib21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00431-005-1758-0","article-title":"Immunisation status of children in Germany: temporal trends and regional differences","volume":"165","author":"Kalies","year":"2006","journal-title":"Eur J Pediatr"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.017_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00019053-200321010-00002","article-title":"Economic evaluations of varicella vaccination programmes: a review of the literature","volume":"21","author":"Thiry","year":"2003","journal-title":"Pharmacoeconomics"},{"issue":"10","key":"10.1016\/j.vaccine.2007.08.017_bib23","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/adc.88.10.862","article-title":"Varicella vaccination in England and Wales: cost-utility analysis","volume":"88","author":"Brisson","year":"2003","journal-title":"Arch Dis Child"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2007.08.017_bib24","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0264-410X(01)00437-6","article-title":"The cost-effectiveness of varicella vaccination in Canada","volume":"20","author":"Brisson","year":"2002","journal-title":"Vaccine"},{"issue":"25","key":"10.1016\/j.vaccine.2007.08.017_bib25","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1016\/j.vaccine.2003.10.042","article-title":"Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology","volume":"23","author":"Goldman","year":"2005","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2007.08.017_bib26","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1469-0691.2004.01020.x","article-title":"Effects of varicella vaccination on herpes zoster incidence","volume":"10","author":"Wagenpfeil","year":"2004","journal-title":"Clin Microbiol Infect"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07009401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07009401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T23:47:33Z","timestamp":1684021653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07009401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":26,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0264410X07009401"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.08.017","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}